Overall rank by patents
#11,338
of 50,000 tracked assignees
USPTO PatentsView assignee record - 27 granted patents across 27 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01B (MEASURING LENGTH, THICKNESS OR SIMILAR LINEAR DIMENSIONS; MEASURING ANGLES; MEASURING AREAS; MEASURING IRREGULARITIES OF SURFACES OR CONTOURS).
The verdict
According to USPTO PatentsView, Marposs ranks #11,338 of 50,000 tracked US assignees by granted-patent volume, with 27 patents across 27 technology areas.
Marposs Societa' Per Azioni has been granted 27 US utility patents between 2015 and 2025, placing Marposs Societa' Per Azioni at #11,338 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 27 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.2 claims per patent with primary concentration in G01B (MEASURING LENGTH, THICKNESS OR SIMILAR LINEAR DIMENSIONS; MEASURING ANGLES; MEASURING AREAS; MEASURING IRREGULARITIES OF SURFACES OR CONTOURS). As a Foreign Corporation, Marposs Societa' Per Azioni is one of the more focused assignees in the PatentsView dataset. By volume, Marposs sits between Micro-epsilon-messtechnik Gmbh & Co. KG (27 patents, rank #11,340) and Micron Devices Llc (27 patents, rank #11,348) - the closest US assignees by grant volume. The composite Innovation Score of 47.8/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 12 grants, compared with 14 in the 2015–2019 window, a -14% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Marposs Societa' Per Azioni's 17.2 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 27 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
MICRO-EPSILON-MESSTECHNIK GMBH & CO. KG
27 patents
MICROELECTRONICS TECHNOLOGY, INC.
27 patents
MISAPPLIED SCIENCES, INC.
27 patents
MLS ACQ, Inc.
27 patents
McLaughlin Gormley King Company
27 patents
McMaster-Carr Supply Company
27 patents
Menarini Silicon Biosystems S.p.A.
27 patents
Micron Devices LLC
27 patents
Marposs Societa' Per Azioni
27 patents
What this shows Marposs holds 27 patents at rank #11,344, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #11,344 in granted patent volume.
Other assignees with the most granted patents in Marposs's primary technology class.
Marposs's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
48 Top 18% higher than 82% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 11.1% |
| 2016 | 2 | 7.4% |
| 2017 | 1 | 3.7% |
| 2018 | 5 | 18.5% |
| 2019 | 3 | 11.1% |
| 2020 | 1 | 3.7% |
| 2021 | 3 | 11.1% |
| 2022 | 4 | 14.8% |
| 2023 | 2 | 7.4% |
| 2024 | 2 | 7.4% |
| 2025partial year | 1 | 3.7% |
Top 15 of 27 technology areas
Historical grant data only; it does not rate legal strength or current strategy.
Overall rank by patents
#11,338
of 50,000 tracked assignees
47.8 out of 100
How to use this portfolio
Marposs's 27 grants land it in the top 18% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.